Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit

NEW YORK (Reuters) - Three of the biggest makers of diabetes treatments, Sanofi SA , Novo Nordisk and Eli Lilly & Co , were named in a class action lawsuit about price fixing filed by a group of patients.

Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit
Read More


Bagikan Berita Ini